Bangladesh vs Least developed countries: Immunization, Hib3
Immunization, Hib3 over time
- Bangladesh
- Least developed countries
How they compare
Bangladesh currently reports 97.0% against 74.4% in Least developed countries, a difference of 22.6%.
That makes Bangladesh's figure about 1.3 times Least developed countries's.
Across all 16 years both countries report, Bangladesh has been ahead every year.
Bangladesh ranks 29th and Least developed countries ranks 30th of 191 countries.
Bangladesh has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bangladesh | Least developed countries | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.0% | 67.2% | 29.8% | Bangladesh |
| 2010s | 95.8% | 75.5% | 20.3% | Bangladesh |
| 2020s | 97.2% | 74.4% | 22.8% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Bangladesh or Least developed countries?
- Bangladesh, at 97.0% against 74.4% in Least developed countries as of 2024.
- What is the difference in immunization, hib3 between Bangladesh and Least developed countries?
- 22.6%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Least developed countries?
- 16 years are reported by both, from 2009 to 2024.
- How do Bangladesh and Least developed countries rank globally for immunization, hib3?
- Bangladesh ranks 29th and Least developed countries ranks 30th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.